Eric Plitman, BSc

  • 2Articles
  • 8.9KReads
  • 2016–2017Active
  • 14Collaborators
  • 118Citations

About

Eric Plitman, BSc, has published research focused on Alzheimer disease, cognition, neurology, and schizophrenia/schizoaffective disorders. His work includes studies on anosognosia as a predictor in mild cognitive impairment progression and dopamine receptor occupancy related to hyperprolactinemia in older schizophrenia patients. Plitman has frequently collaborated with colleagues such as Ariel Graff-Guerrero and Bruce G. Pollock. His articles appeared in Psychiatrist.com between 2016 and 2017.

Publications

JCP
Original Research

Anosognosia in MCI and AD

October 10, 2017

Although anosognosia—or impaired illness awareness—is common in Alzheimer's disease, it occurs less frequently in mild cognitive impairment. Read this article to learn if anosognosia in patients with mild cognitive...
, , , et al
JCP
Article

Hyperprolactinemia in Older Patients With Schizophrenia

December 28, 2016

Since older patients are known to be hypersensitive to antipsychotics, are they vulnerable to developing hyperprolactinemia with these drugs? This post hoc study looked at whether the dopamine D2/3...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe